Should I Increase My Mounjaro Dose?

You're four weeks in and wondering if it's time to move up

This is a question our prescribers hear most weeks. You've finished your first pen, side effects have eased off, and you're not sure whether to ask about going up. That uncertainty is completely normal. The licensed titration schedule for Mounjaro works on roughly four-week intervals, each pen runs for four doses, and once you've completed it without significant problems, moving up is usually on the table.

But four weeks at a dose is a floor, not a trigger. Your prescriber is looking at two things together: whether you tolerated the current strength reasonably well, and whether there's a clinical reason to increase. Ongoing nausea, vomiting, or persistent GI symptoms are signals that your body may need more time where it is. If those have settled and your overall response suggests the higher dose would be appropriate, your prescriber can move you forward. The NHS patient-level guidance on tirzepatide explains this staged approach, you can read it on the NHS medicines page for tirzepatide.

The 2.5mg starting dose deserves a word here. Its job is adjustment. Appetite reduction and meaningful weight loss come at higher doses; 2.5mg is the foundation. Staying there beyond the initial four weeks without a clinical reason isn't recommended, but equally, rushing through the schedule to reach 15mg faster isn't the aim either.

What side effects tell your prescriber about your readiness

Gastrointestinal effects (nausea, loose stools, indigestion, burping) are the most common reason a dose increase gets delayed rather than cancelled. They tend to be worst in the first one to two weeks after a new dose, then ease. If they haven't eased by the time a new pen is due, that's clinically relevant information.

Severe or persistent stomach pain is different from ordinary nausea and needs prompt attention, not a dose adjustment. The MHRA's January 2026 Drug Safety Update for GLP-1 medicines flagged acute pancreatitis as an infrequent but serious possibility; severe pain that radiates to the back, with or without vomiting, warrants urgent medical help, not watchful waiting. You can report suspected side effects through the MHRA Yellow Card scheme.

Mild nausea that's improving is not a reason to stay put indefinitely. It's a normal part of the adjustment process, and most people find it significantly better by weeks two or three. If you're at 5mg and wondering whether that dose's tolerability profile changes things, there's more detail in the guide to Mounjaro nausea at 5mg.

When a dose increase isn't the next step

Not everyone moves steadily through all six strengths, and that's fine. Some people respond well at 10mg and never need to go further. Others reach the highest tolerated dose (a phrase that appears in both the SmPC and NICE's appraisal of tirzepatide (TA1026)) meaning the level at which benefits continue without unacceptable side effects. That's the goal, not the maximum dose on the label.

There's also a question of whether you actually need to go up. If weight loss is progressing steadily and you're tolerating the current dose well, your prescriber may recommend staying there for a further cycle before reassessing. Dose increases are a tool, not a schedule to sprint through. If you're asking yourself whether you should up your dose of Mounjaro, the answer is more nuanced than a simple yes or no.

Transfer patients joining from another provider (or anyone requesting a dose increase at nume) will need to provide evidence of their current treatment before a change is made. That's part of how clinical oversight works in practice, not a hoop to jump through. For more on the factors that go into that decision, the reasons behind a Mounjaro dose increase covers the clinical rationale in more depth.

Getting the right clinical input before your next pen

Dose decisions live with your prescriber, not with a forum thread or a checklist. Every repeat order at nume is clinically reviewed before dispatch, a real prescriber reads your notes, not software. That review is what makes it safe to move through the dose schedule, and it's also what catches the situations where staying put is the better call.

If you're on Mounjaro privately and thinking about your next dose, or you're considering starting treatment, the full Mounjaro overview covers eligibility and how treatment works from the beginning. For context on what treatment costs and what a legitimate price includes, the guide to Mounjaro pricing in the UK is worth a read before you compare providers. When you're ready to speak to a prescriber, check your eligibility for a free consultation.